Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 7Radiotherapy 5Cisplatin 5pembrolizumab 3Paclitaxel 3Fluorouracil 3Cetuximab 3Biopsy 3(225)Ac-DOTA-c(RGDyK) 3ipatasertib 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Platinum 2Immunoglobulin G 2Gemcitabine 2Fluorodeoxyglucose F18 2Disulfides 21,2-diaminocyclohexaneplatinum II citrate 2peposertib 1fluoromisonidazole 1eniluracil 1durvalumab 1dl1520 1cabozantinib 1atezolizumab 1Rubidium-82 1Ritonavir 1Radiation 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Hypopharyngeal Neoplasms × dl1520 × Clear all
NCT00006106 2013-07-10

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Withdrawn
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡